Arama Sonuçları - Manuel Romero‐Gómez
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 147
- Sonraki Sayfaya Git
-
1
Insulin resistance and hepatitis C Yazar: Manuel Romero‐Gómez
Baskı/Yayın Bilgisi 2006Artigo -
2
The role of nutrition in non‐alcoholic fatty liver disease: Pathophysiology and management Yazar: Genoveva Berná, Manuel Romero‐Gómez
Baskı/Yayın Bilgisi 2020Revisão -
3
Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach Yazar: Carmen Lara, Manuel Romero‐Gómez
Baskı/Yayın Bilgisi 2024Artigo -
4
Steatosis and insulin resistance in hepatitis C: A way out for the virus? Yazar: J.A. Del Campo, Manuel Romero‐Gómez
Baskı/Yayın Bilgisi 2009Revisão -
5
Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure Yazar: Manuel Romero‐Gómez, Sara Montagnese, Rajiv Jalan
Baskı/Yayın Bilgisi 2014Revisão -
6
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment Yazar: Manuel Romero‐Gómez, Eslam Mohamed, Agustı́n Ruiz, M. Maraver
Baskı/Yayın Bilgisi 2011Revisão -
7
Irisin, a Link among Fatty Liver Disease, Physical Inactivity and Insulin Resistance Yazar: M. Arias, Isidora Ranchal, Manuel Romero‐Gómez, Javier Crespo
Baskı/Yayın Bilgisi 2014Revisão -
8
Treatment of NAFLD with diet, physical activity and exercise Yazar: Manuel Romero‐Gómez, Shira Zelber‐Sagi, Michael I. Trenell
Baskı/Yayın Bilgisi 2017Revisão -
9
Role of assessing liver fibrosis in management of chronic hepatitis C virus infection Yazar: Inmaculada Tomás, Patricia Cordero, Javier Ampuero, Ángela Rojas, Manuel Romero‐Gómez
Baskı/Yayın Bilgisi 2016Revisão -
10
-
11
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease Yazar: Francisco Barrera, Javier Uribe, Nixa Olvares, Paula Huerta, Daniel Cabrera, Manuel Romero‐Gómez
Baskı/Yayın Bilgisi 2024Artigo -
12
Wilson's disease: Revisiting an old friend Yazar: Ana Lucena-Valera, Domingo Perez-Palacios, Rocío Múñoz‐Hernández, Manuel Romero‐Gómez, Javier Ampuero
Baskı/Yayın Bilgisi 2021Revisão -
13
Metabolic dysfunction: The silenced connection with fatty liver disease Yazar: Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero‐Gómez, Mohammed Eslam, Nahúm Méndez‐Sánchez
Baskı/Yayın Bilgisi 2023Revisão -
14
Meta‐analysis: insulin resistance and sustained virological response in hepatitis C Yazar: Mohammed Eslam, R. Aparcero, Takumi Kawaguchi, J.A. Del Campo, M Sata, Mahmoud Khattab, Manuel Romero‐Gómez
Baskı/Yayın Bilgisi 2011Revisão -
15
Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines Yazar: Christopher Randolph, Robin C. Hilsabeck, Ainobu Kato, P Kharbanda, Yuyuan Li, Daniela Mapelli, Lisa Ravdin, Manuel Romero‐Gómez, Andrea Stracciari, Karin Weißenborn
Baskı/Yayın Bilgisi 2009Revisão -
16
miRNAs in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis Yazar: Chang‐Hai Liu, Javier Ampuero, Antonio Gil‐Gómez, Rocío Montero‐Vallejo, Ángela Rojas, Rocío Múñoz‐Hernández, Rocío Gallego‐Durán, Manuel Romero‐Gómez
Baskı/Yayın Bilgisi 2018Revisão -
17
Improved health‐related quality of life with semaglutide in people with non‐alcoholic steatohepatitis: A randomised trial Yazar: Manuel Romero‐Gómez, Matthew J. Armstrong, Jesús Funuyet‐Salas, Kamal Kant Mangla, Steen Ladelund, Anne‐Sophie Sejling, Ichhya Shrestha, Arun J. Sanyal
Baskı/Yayın Bilgisi 2023Artigo -
18
Microbiome-Centered Therapies for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease Yazar: Huma Saeed, Luis Antonio Díaz, Antonio Gil‐Gómez, Jeremy P. Burton, Jasmohan S. Bajaj, Manuel Romero‐Gómez, Marco Arrese, Juan Pablo Arab, Qasim Khan
Baskı/Yayın Bilgisi 2024Revisão -
19
HLA Alleles Influence the Clinical Signature of Amoxicillin-Clavulanate Hepatotoxicity Yazar: Camilla Stephens, Miguel Ángel López‐Nevot, Francisco Ruíz-Cabello, Eugenia Ulzurrun, Germán Soriano, Manuel Romero‐Gómez, Antonia Moreno-Casares, M. Isabel Lucena, Raúl J. Andrade
Baskı/Yayın Bilgisi 2013Artigo -
20
A European Survey to Identify Challenges in the Management of Metabolic Dysfunction‐Associated Steatotic Liver Disease Yazar: Laurent Castéra, William Alazawi, Elisabetta Bugianesi, Cyrielle Caussy, Massimo Federici, Manuel Romero‐Gómez, Jörn M. Schattenberg, Ron Basuroy, Preethy Prasad, Dmitry Estulin, Jeffrey V. Lazarus
Baskı/Yayın Bilgisi 2025Artigo
Arama Araçları:
İlgili Konular
Medicine
Internal medicine
Disease
Gastroenterology
Fatty liver
Cirrhosis
Biology
Steatohepatitis
Pathology
Liver disease
Nonalcoholic fatty liver disease
Fibrosis
Immunology
Endocrinology
Biochemistry
Environmental health
Intensive care medicine
Virus
Chemistry
Gene
Biopsy
Genetics
Hepatitis C virus
Steatosis
Liver biopsy
Obesity
Computer science
Hepatitis C
Virology
Cohort